While ANRIL was reported to downregulate P15 and P16 expression by interacting with components of polycomb repressive complex-1/-2 [2–5], ANRIL was also found to be coordinately transcribed with P16 in cancer cells and transcriptionally repressed by P16 DNA methylation [6]. The gene discussed is CDKN2B-AS1; the disease is cancer.